• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甲氨蝶呤聚乙二醇酯作为药物递送系统的合成与表征

Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system.

作者信息

Yousefi Gholamhossein, Foroutan Seyed Mohsen, Zarghi Afshin, Shafaati Alireza

机构信息

Department of Pharmaceutics, School of Pharmacy, Shaheed Beheshti University of Medical Sciences, 14155-6153, Iran.

出版信息

Chem Pharm Bull (Tokyo). 2010 Feb;58(2):147-53. doi: 10.1248/cpb.58.147.

DOI:10.1248/cpb.58.147
PMID:20118571
Abstract

Methotrexate (MTX) is one of the most common anticancer drugs used for chemotherapy so far. However some problems such as high toxicity and short plasma half-life, have limited its use. To overcome these limitations, conjugation with polymers such as polyethylene glycol (PEG) is one the efficient approaches which has been attempted in recent years. The aim of the present study is to synthesize esters of MTX with PEGs of different molecular weights and to characterize their physicochemical properties. Polymeric esters (MTX-PEGs) of MTX with low, medium and high molecular weight PEGs (750 D, 5000 D and 35000 D, respectively) were synthesized using dicyclohexylcarbodiimide (DCC) as coupling agent and triethylamine (TEA) as catalyst. The purification was carried out using preparative TLC. Purified esters were characterized by UV, IR and (1)H-NMR spectroscopy methods and their thermal behavior was studied by differential scanning calorimetry (DSC). Also, an isocratic HPLC method with three mobile phase systems was set to determine the partition coefficient of the esters (log P). Gel permeation chromatography (GPC) was utilized for molecular weight determination of esters, which proved 1 : 1 conjugation of drug with each polymer. The stability and solubility of esters were determined in different pH values. The spectroscopy results indicated that esteric bond between MTX and PEGs were formed. The sharp endothermic peaks for MTX-PEGs were obtained in DSC which are similar to pure polymers, whilst a wide peak was observed for MTX. The values of log P for MTX-PEGs (+4.3, obtained by HPLC method) were remarkably different from log P of MTX (-1.4, obtained by shake-flask method). The stability results showed a pH range of 3-4 and an optimum polymer mw of 5000 for maximum stability of esters. A parabolic profile obtained from solubility studies that indicated the more solubility of MTX in alkaline condition (pH>5) and MTX-PEGs in acidic conditions (pH<5). Based on our results, it is concluded that MTX-PEGs were formed on an equimolar ratio of MTX and PEGs. The higher log P observed for the esters indicated dramatic physicochemical differences between MTX and its PEG conjugates and the higher stability and solubility in acidic medium showed a promising approach to improve the drug delivery of the conjugates, specially MTX-PEG5000 in the future.

摘要

甲氨蝶呤(MTX)是目前用于化疗的最常见抗癌药物之一。然而,诸如高毒性和血浆半衰期短等问题限制了其应用。为克服这些局限性,与聚乙二醇(PEG)等聚合物共轭是近年来尝试的有效方法之一。本研究的目的是合成MTX与不同分子量PEG的酯,并表征其理化性质。以二环己基碳二亚胺(DCC)为偶联剂、三乙胺(TEA)为催化剂,合成了MTX与低、中、高分子量PEG(分别为750 D、5000 D和35000 D)的聚合物酯(MTX-PEGs)。采用制备型薄层色谱进行纯化。通过紫外光谱、红外光谱和(1)H-NMR光谱法对纯化后的酯进行表征,并通过差示扫描量热法(DSC)研究其热行为。此外,建立了一种采用三种流动相系统的等度高效液相色谱法来测定酯的分配系数(log P)。利用凝胶渗透色谱法(GPC)测定酯的分子量,结果证明药物与每种聚合物以1:1的比例共轭。在不同pH值下测定酯的稳定性和溶解度。光谱结果表明MTX与PEGs之间形成了酯键。在DSC中,MTX-PEGs出现尖锐的吸热峰,与纯聚合物相似,而MTX出现宽峰。MTX-PEGs的log P值(通过高效液相色谱法测得为+4.3)与MTX的log P值(通过摇瓶法测得为-1.4)显著不同。稳定性结果表明,酯的最大稳定性对应的pH范围为3-4,最佳聚合物分子量为5000。溶解度研究得到的抛物线表明,MTX在碱性条件下(pH>5)溶解度更高,而MTX-PEGs在酸性条件下(pH<5)溶解度更高。根据我们的结果得出结论,MTX和PEGs以等摩尔比形成了MTX-PEGs。酯的log P值较高,表明MTX与其PEG共轭物之间存在显著的理化差异,且在酸性介质中具有更高的稳定性和溶解度,这显示了一种有望改善共轭物药物递送的方法,特别是未来的MTX-PEG5000。

相似文献

1
Synthesis and characterization of methotrexate polyethylene glycol esters as a drug delivery system.甲氨蝶呤聚乙二醇酯作为药物递送系统的合成与表征
Chem Pharm Bull (Tokyo). 2010 Feb;58(2):147-53. doi: 10.1248/cpb.58.147.
2
Polyethylene glycol conjugates of methotrexate varying in their molecular weight from MW 750 to MW 40000: synthesis, characterization, and structure-activity relationships in vitro and in vivo.甲氨蝶呤的聚乙二醇缀合物,分子量在750至40000之间:体外和体内的合成、表征及构效关系
Bioconjug Chem. 2002 Jul-Aug;13(4):773-85. doi: 10.1021/bc010098m.
3
Methotrexate esters of poly(ethylene oxide)-block-poly(2-hydroxyethyl-L-aspartamide). Part I: Effects of the level of methotrexate conjugation on the stability of micelles and on drug release.聚(环氧乙烷)-嵌段-聚(2-羟乙基-L-天冬酰胺)的甲氨蝶呤酯。第一部分:甲氨蝶呤缀合水平对胶束稳定性和药物释放的影响。
Pharm Res. 2000 May;17(5):607-11. doi: 10.1023/a:1007529218802.
4
Synthesis, characterization, and kinetic release study of methotrexate loaded mPEG-PCL polymersomes for inhibition of MCF-7 breast cancer cell line.载甲氨蝶呤的 mPEG-PCL 聚合物囊泡的合成、表征及动力学释放研究用于 MCF-7 乳腺癌细胞系的抑制。
Pharm Dev Technol. 2019 Jan;24(1):89-98. doi: 10.1080/10837450.2018.1425433. Epub 2018 Jan 18.
5
Characterization and in vitro methotrexate release from methotrexate/gelatin conjugates of opposite conjugate bond polarity.具有相反共轭键极性的甲氨蝶呤/明胶共轭物的表征及甲氨蝶呤的体外释放
Pharm Res. 2000 Oct;17(10):1309-15. doi: 10.1023/a:1026460023503.
6
Combination of β-cyclodextrin inclusion complex and self-microemulsifying drug delivery system for photostability and enhanced oral bioavailability of methotrexate: novel technique.β-环糊精包合物与自微乳药物传递系统联合提高甲氨蝶呤的光稳定性和口服生物利用度:新技术。
Drug Dev Ind Pharm. 2013 Jun;39(6):918-27. doi: 10.3109/03639045.2012.718785. Epub 2012 Sep 24.
7
Characterization and in vitro release of methotrexate from gelatin/methotrexate conjugates formed using different preparation variables.使用不同制备变量形成的明胶/甲氨蝶呤缀合物中甲氨蝶呤的表征及体外释放
Int J Pharm. 2000 Aug 25;204(1-2):81-9. doi: 10.1016/s0378-5173(00)00476-2.
8
Macromolecular bipill of gemcitabine and methotrexate facilitates tumor-specific dual drug therapy with higher benefit-to-risk ratio.吉西他滨和甲氨蝶呤大分子双丸剂有助于肿瘤特异性双药治疗,具有更高的风险效益比。
Bioconjug Chem. 2014 Mar 19;25(3):501-9. doi: 10.1021/bc400477q. Epub 2014 Feb 19.
9
Synthesis, characterization and pH-controllable methotrexate release from biocompatible polymer/silica nanocomposite for anticancer drug delivery.生物相容性聚合物/二氧化硅纳米复合材料的合成、表征及 pH 可控的甲氨蝶呤释放用于抗癌药物输送。
Drug Deliv. 2014 May;21(3):155-63. doi: 10.3109/10717544.2013.838714. Epub 2013 Oct 10.
10
Construction of pH-sensitive lysozyme/pectin nanogel for tumor methotrexate delivery.构建 pH 敏感的溶菌酶/果胶纳米凝胶用于肿瘤甲氨蝶呤递送。
Colloids Surf B Biointerfaces. 2015 Feb 1;126:459-66. doi: 10.1016/j.colsurfb.2014.12.051. Epub 2015 Jan 6.

引用本文的文献

1
Integrating Nanotechnological Advancements of Disease-Modifying Anti-Rheumatic Drugs into Rheumatoid Arthritis Management.将改善病情的抗风湿药物的纳米技术进展整合到类风湿关节炎的管理中。
Pharmaceuticals (Basel). 2024 Feb 14;17(2):248. doi: 10.3390/ph17020248.
2
β-Cyclodextrin Modified Hydrogels of Kappa-Carrageenan for Methotrexate Delivery.用于甲氨蝶呤递送的κ-卡拉胶β-环糊精修饰水凝胶
Pharmaceutics. 2023 Aug 30;15(9):2244. doi: 10.3390/pharmaceutics15092244.
3
Dual-Enhanced Pluronic Nanoformulated Methotrexate-Based Treatment Approach for Breast Cancer: Development and Evaluation of In Vitro and In Vivo Efficiency.
基于双增强普朗尼克纳米制剂的甲氨蝶呤乳腺癌治疗方法:体外和体内效率的开发与评估
Pharmaceutics. 2022 Nov 30;14(12):2668. doi: 10.3390/pharmaceutics14122668.
4
Pharmacokinetics and Biodistribution of Pegylated Methotrexate after IV Administration to Mice.聚乙二醇化甲氨蝶呤静脉注射给小鼠后的药代动力学和生物分布
Iran J Pharm Res. 2018;17(Suppl2):111-123.
5
Toxicity, Biocompatibility, pH-Responsiveness and Methotrexate Release from PVA/Hyaluronic Acid Cryogels for Psoriasis Therapy.用于银屑病治疗的聚乙烯醇/透明质酸冷冻凝胶的毒性、生物相容性、pH响应性及甲氨蝶呤释放
Polymers (Basel). 2017 Mar 27;9(4):123. doi: 10.3390/polym9040123.
6
Preparation and assessment of chitosan-coated superparamagnetic Fe3O4 nanoparticles for controlled delivery of methotrexate.用于甲氨蝶呤控释的壳聚糖包覆超顺磁性Fe3O4纳米粒子的制备与评估
Res Pharm Sci. 2013 Jan;8(1):25-33.
7
Design and evaluation of xanthine based adenosine receptor antagonists: potential hypoxia targeted immunotherapies.基于黄嘌呤的腺嘌呤受体拮抗剂的设计与评价:潜在的缺氧靶向免疫疗法。
Bioorg Med Chem. 2013 Dec 1;21(23):7453-64. doi: 10.1016/j.bmc.2013.09.043. Epub 2013 Sep 28.
8
Enhanced anti-tumoral activity of methotrexate-human serum albumin conjugated nanoparticles by targeting with Luteinizing Hormone-Releasing Hormone (LHRH) peptide.通过用促黄体生成素释放激素(LHRH)肽靶向作用,甲氨蝶呤-人血清白蛋白偶联纳米颗粒的抗肿瘤活性增强。
Int J Mol Sci. 2011;12(7):4591-608. doi: 10.3390/ijms12074591. Epub 2011 Jul 15.